RxDoctor Payments Data

Brianne Willis, APRN

Family · Point Pleasant, WVNPI 1457723389

Payments from drug & device makers

$591in general payments, 2019–2025

Across 32 payments — averaging $18.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$245
  • Abbott$63
  • Lilly USA, LLC$48
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$48
  • GSK$35
  • Exact Sciences$30
  • plus $122 from 6 others

What the payments were for

  • Food & beverage$591100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$591 in reported general payments places this provider in the 55th percentile of 1,507 family providers in West Virginia.

See all family providers in West Virginia

Medicare billing

Part B allowed, 2024
$59,960
Medicare patients
181
Services billed
747

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin43$64,457
OzempicSemaglutide29$44,694
MounjaroTirzepatide26$43,283
EliquisApixaban39$37,528
Spiriva RespimatTiotropium Bromide23$14,793
Breo ElliptaFluticasone/Vilanterol36$14,585
Repatha SureclickEvolocumab12$10,258
Trelegy ElliptaFluticasone/Umeclidin/Vilanter12$7,633
Incruse ElliptaUmeclidinium Bromide11$3,830
Atorvastatin Calcium264$2,396
Losartan Potassium239$2,301
Rosuvastatin Calcium184$1,971
Levothyroxine Sodium209$1,821
Duloxetine Hcl71$1,810
Potassium Chloride81$1,642

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro$48$43,28326 claims
GSKBreo Ellipta, Trelegy Ellipta, Incruse Ellipta$35$26,04859 claims
AbbVieSynthroid$245$74635 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 1,507 family providers in West Virginia.

Other family in Point Pleasant

See the full list for West Virginia

Where these figures come from

Is this you, or does something look wrong? →